- Published on
Theophylline poisoning is a potentially life-threatening toxicologic emergency resulting from excessive levels of a methylxanthine drug commonly used for respiratory conditions. Its toxicity is primarily due to increased endogenous catecholamine release, antagonism of adenosine receptors, and inhibition of phosphodiesterase at high concentrations. These mechanisms lead to widespread stimulation of the cardiovascular and central nervous systems. Theophylline is available in both immediate-release and sustained-release formulations, with peak absorption occurring within 1–2 hours for immediate-release and up to 6–10 hours for sustained-release forms, which can delay toxicity.
Toxicity can occur in several patterns. Acute overdose refers to a large ingestion in a patient without prior exposure, whereas acute-on-chronic toxicity occurs when a patient already on therapy takes an excessive dose. Chronic toxicity develops gradually due to accumulation, often from drug interactions, organ dysfunction such as liver disease or heart failure, or repeated dosing errors. Importantly, chronic toxicity tends to cause severe symptoms at lower serum levels compared to acute overdose.
Clinically, theophylline poisoning affects multiple organ systems. Cardiovascular manifestations include sinus tachycardia, atrial and ventricular dysrhythmias, and in severe cases ventricular tachycardia due to β1 stimulation and adenosine antagonism. Hypotension may occur at very high levels due to β2-mediated vasodilation and can be resistant to standard treatments. Neurologically, patients may present with tremors, agitation, altered mental status, and seizures, which are a hallmark of severe toxicity and occur more frequently in chronic intoxication. Gastrointestinal symptoms are common, particularly persistent nausea and vomiting, which can be severe and refractory.
Metabolic abnormalities are also prominent, including hypokalemia due to intracellular potassium shift, hyperglycemia, leukocytosis, and metabolic acidosis with elevated lactate. Hypophosphatemia and hypomagnesemia may also occur. Sustained-release formulations may form pharmacobezoars in the gastrointestinal tract, delaying absorption and prolonging toxicity.
Diagnosis is confirmed by measuring serum theophylline levels, with concentrations ≥20 μg/mL considered toxic. Serial levels are essential to ensure that peak levels have been reached, especially with sustained-release products. Electrocardiographic monitoring is critical due to the high risk of dysrhythmias. Additional laboratory testing helps assess complications such as electrolyte disturbances and metabolic derangements.
Management begins with stabilization of airway, breathing, and circulation, along with cardiac monitoring. Intravenous fluids are administered for hypotension, and rate control for supraventricular tachyarrhythmias may require β-blockers or calcium channel blockers. Notably, adenosine is often ineffective because its action is antagonized by theophylline. Ventricular dysrhythmias are treated according to standard protocols. Seizures should be treated aggressively with benzodiazepines, as other agents such as phenytoin are ineffective and may worsen outcomes.
Gastrointestinal decontamination plays a major role in treatment. Activated charcoal is highly effective, particularly when given in multiple doses, as it enhances elimination by interrupting enterohepatic circulation. Whole-bowel irrigation may be used for sustained-release ingestions to remove unabsorbed drug. Antiemetics such as metoclopramide or ondansetron may be required for severe vomiting. Electrolyte abnormalities should be corrected cautiously, especially hypokalemia, to avoid rebound hyperkalemia as drug levels fall.
In severe cases, extracorporeal removal such as hemodialysis or hemoperfusion is indicated, particularly in patients with very high serum levels, refractory seizures, or significant dysrhythmias. These methods are highly effective due to theophylline’s pharmacokinetic properties.
Patients with severe toxicity, high serum levels, or complications such as seizures or refractory hypotension require intensive care admission. Those with mild symptoms may be discharged once serum levels are clearly decreasing and below toxic thresholds, provided they remain clinically stable. Close follow-up is necessary, especially in patients on chronic therapy, to adjust dosing and prevent recurrence.
A key point in theophylline poisoning is that seizures and tachydysrhythmias are major causes of morbidity and mortality, and early recognition with aggressive treatment significantly improves outcomes. Multi-dose activated charcoal remains one of the most effective interventions in enhancing drug elimination.
Toxicity can occur in several patterns. Acute overdose refers to a large ingestion in a patient without prior exposure, whereas acute-on-chronic toxicity occurs when a patient already on therapy takes an excessive dose. Chronic toxicity develops gradually due to accumulation, often from drug interactions, organ dysfunction such as liver disease or heart failure, or repeated dosing errors. Importantly, chronic toxicity tends to cause severe symptoms at lower serum levels compared to acute overdose.
Clinically, theophylline poisoning affects multiple organ systems. Cardiovascular manifestations include sinus tachycardia, atrial and ventricular dysrhythmias, and in severe cases ventricular tachycardia due to β1 stimulation and adenosine antagonism. Hypotension may occur at very high levels due to β2-mediated vasodilation and can be resistant to standard treatments. Neurologically, patients may present with tremors, agitation, altered mental status, and seizures, which are a hallmark of severe toxicity and occur more frequently in chronic intoxication. Gastrointestinal symptoms are common, particularly persistent nausea and vomiting, which can be severe and refractory.
Metabolic abnormalities are also prominent, including hypokalemia due to intracellular potassium shift, hyperglycemia, leukocytosis, and metabolic acidosis with elevated lactate. Hypophosphatemia and hypomagnesemia may also occur. Sustained-release formulations may form pharmacobezoars in the gastrointestinal tract, delaying absorption and prolonging toxicity.
Diagnosis is confirmed by measuring serum theophylline levels, with concentrations ≥20 μg/mL considered toxic. Serial levels are essential to ensure that peak levels have been reached, especially with sustained-release products. Electrocardiographic monitoring is critical due to the high risk of dysrhythmias. Additional laboratory testing helps assess complications such as electrolyte disturbances and metabolic derangements.
Management begins with stabilization of airway, breathing, and circulation, along with cardiac monitoring. Intravenous fluids are administered for hypotension, and rate control for supraventricular tachyarrhythmias may require β-blockers or calcium channel blockers. Notably, adenosine is often ineffective because its action is antagonized by theophylline. Ventricular dysrhythmias are treated according to standard protocols. Seizures should be treated aggressively with benzodiazepines, as other agents such as phenytoin are ineffective and may worsen outcomes.
Gastrointestinal decontamination plays a major role in treatment. Activated charcoal is highly effective, particularly when given in multiple doses, as it enhances elimination by interrupting enterohepatic circulation. Whole-bowel irrigation may be used for sustained-release ingestions to remove unabsorbed drug. Antiemetics such as metoclopramide or ondansetron may be required for severe vomiting. Electrolyte abnormalities should be corrected cautiously, especially hypokalemia, to avoid rebound hyperkalemia as drug levels fall.
In severe cases, extracorporeal removal such as hemodialysis or hemoperfusion is indicated, particularly in patients with very high serum levels, refractory seizures, or significant dysrhythmias. These methods are highly effective due to theophylline’s pharmacokinetic properties.
Patients with severe toxicity, high serum levels, or complications such as seizures or refractory hypotension require intensive care admission. Those with mild symptoms may be discharged once serum levels are clearly decreasing and below toxic thresholds, provided they remain clinically stable. Close follow-up is necessary, especially in patients on chronic therapy, to adjust dosing and prevent recurrence.
A key point in theophylline poisoning is that seizures and tachydysrhythmias are major causes of morbidity and mortality, and early recognition with aggressive treatment significantly improves outcomes. Multi-dose activated charcoal remains one of the most effective interventions in enhancing drug elimination.
- Published on
Emergency and Acute Medicine – Tibial Plateau Fracture
Tibial plateau fractures are serious intra-articular injuries involving the proximal tibia that can compromise knee stability and function. These fractures occur when axial loading is combined with valgus or varus forces, leading to splitting or depression of the articular surface. They are commonly classified using the Schatzker system, which ranges from low-energy lateral plateau fractures (types 1–3) to high-energy bicondylar and comminuted fractures (types 4–6), the latter often associated with significant soft tissue, ligamentous, and neurovascular injuries.
The mechanism of injury varies with fracture type. Low-energy injuries, such as those seen in sports or minor trauma, often produce lateral plateau fractures, particularly in younger individuals or those with relatively strong bone. In contrast, high-energy mechanisms such as motor vehicle collisions or falls from height tend to produce more severe medial or bicondylar fractures and are frequently associated with complications such as popliteal artery injury, peroneal nerve damage, and compartment syndrome.
Clinically, patients present with knee pain, swelling, and inability to bear weight. Examination may reveal joint effusion, limited range of motion, tenderness over the proximal tibia, and possible deformity or instability of the knee. A thorough neurovascular examination is essential, particularly in high-energy injuries, as vascular compromise or nerve injury can have limb-threatening consequences. Findings such as diminished pulses, sensory deficits, or weakness in ankle dorsiflexion should raise concern for serious complications.
Radiographic evaluation begins with plain X-rays, including specialized views to assess the tibial plateau and joint surface. Findings may include fracture lines, depression of the articular surface, or lipohemarthrosis, which is highly suggestive of an intra-articular fracture. Computed tomography is often used to better characterize fracture patterns, while MRI may be helpful in identifying associated ligamentous or meniscal injuries. In cases of suspected vascular injury, arteriography may be indicated but should not delay urgent intervention.
Initial management focuses on stabilization, pain control, and prevention of further injury. The affected limb should be immobilized in a long leg splint with the knee in extension, and the patient should remain non–weight bearing. Ice and elevation are important to reduce swelling. In cases of open fractures, prompt antibiotic administration, tetanus prophylaxis, and surgical consultation are required.
Stable, minimally displaced fractures without ligamentous injury may be managed conservatively with immobilization and close follow-up. However, unstable fractures, those with significant displacement, or injuries associated with vascular compromise or compartment syndrome require urgent orthopedic evaluation and often surgical intervention. High-energy injuries may also require hospital admission for monitoring due to the risk of delayed compartment syndrome.
A key clinical consideration is the potential for associated popliteal artery injury in high-energy mechanisms, which can be limb-threatening if missed. Additionally, tibial plateau fractures can be subtle on initial imaging, and a high index of suspicion is necessary, particularly when clinical findings are disproportionate to radiographic results.
Tibial plateau fractures are serious intra-articular injuries involving the proximal tibia that can compromise knee stability and function. These fractures occur when axial loading is combined with valgus or varus forces, leading to splitting or depression of the articular surface. They are commonly classified using the Schatzker system, which ranges from low-energy lateral plateau fractures (types 1–3) to high-energy bicondylar and comminuted fractures (types 4–6), the latter often associated with significant soft tissue, ligamentous, and neurovascular injuries.
The mechanism of injury varies with fracture type. Low-energy injuries, such as those seen in sports or minor trauma, often produce lateral plateau fractures, particularly in younger individuals or those with relatively strong bone. In contrast, high-energy mechanisms such as motor vehicle collisions or falls from height tend to produce more severe medial or bicondylar fractures and are frequently associated with complications such as popliteal artery injury, peroneal nerve damage, and compartment syndrome.
Clinically, patients present with knee pain, swelling, and inability to bear weight. Examination may reveal joint effusion, limited range of motion, tenderness over the proximal tibia, and possible deformity or instability of the knee. A thorough neurovascular examination is essential, particularly in high-energy injuries, as vascular compromise or nerve injury can have limb-threatening consequences. Findings such as diminished pulses, sensory deficits, or weakness in ankle dorsiflexion should raise concern for serious complications.
Radiographic evaluation begins with plain X-rays, including specialized views to assess the tibial plateau and joint surface. Findings may include fracture lines, depression of the articular surface, or lipohemarthrosis, which is highly suggestive of an intra-articular fracture. Computed tomography is often used to better characterize fracture patterns, while MRI may be helpful in identifying associated ligamentous or meniscal injuries. In cases of suspected vascular injury, arteriography may be indicated but should not delay urgent intervention.
Initial management focuses on stabilization, pain control, and prevention of further injury. The affected limb should be immobilized in a long leg splint with the knee in extension, and the patient should remain non–weight bearing. Ice and elevation are important to reduce swelling. In cases of open fractures, prompt antibiotic administration, tetanus prophylaxis, and surgical consultation are required.
Stable, minimally displaced fractures without ligamentous injury may be managed conservatively with immobilization and close follow-up. However, unstable fractures, those with significant displacement, or injuries associated with vascular compromise or compartment syndrome require urgent orthopedic evaluation and often surgical intervention. High-energy injuries may also require hospital admission for monitoring due to the risk of delayed compartment syndrome.
A key clinical consideration is the potential for associated popliteal artery injury in high-energy mechanisms, which can be limb-threatening if missed. Additionally, tibial plateau fractures can be subtle on initial imaging, and a high index of suspicion is necessary, particularly when clinical findings are disproportionate to radiographic results.
- Published on
Emergency and Acute Medicine – Tibial/Fibular Shaft Fracture
Tibial and fibular shaft fractures are common long bone injuries, often resulting from trauma ranging from low-energy twisting mechanisms to high-energy direct blows such as motor vehicle collisions. The tibia is particularly vulnerable due to its subcutaneous location, and approximately 80% of tibial fractures are associated with a fibular fracture. A significant proportion (around 24%) are open fractures, making soft tissue assessment critically important.
Fractures are classified based on location (proximal, midshaft, distal), pattern (spiral, transverse, oblique, comminuted), displacement, and degree of soft tissue injury. Open fractures are further categorized using the Gustilo–Anderson classification, which ranges from type I (minimal soft tissue injury) to type III (severe soft tissue damage, including neurovascular compromise).
The mechanism of injury provides important clues. Low-energy injuries (e.g., falls, sports, twisting forces) tend to produce spiral or oblique fractures, whereas high-energy trauma (e.g., pedestrian vs. vehicle, crush injuries) often results in transverse or comminuted fractures with significant soft tissue damage. In children, special patterns such as toddler fractures (spiral distal tibia fractures) and bicycle spoke injuries should be recognized, as well as the possibility of nonaccidental trauma.
Patients typically present with severe localized pain, inability to bear weight (especially with tibial involvement), swelling, and deformity. On examination, clinicians must carefully assess for neurovascular compromise, including pulses, sensation, and motor function. Injury to the peroneal nerve, particularly with proximal fibular fractures, may lead to foot drop.
A key and potentially limb-threatening complication is compartment syndrome, which occurs in up to 8% of tibial shaft fractures. It may develop hours after injury and is characterized by pain out of proportion to the injury, pain with passive stretch, and progressive neurologic deficits. Importantly, pulses are usually still present, so their presence does not exclude the diagnosis. Early recognition is critical, as delayed treatment can result in permanent muscle and nerve damage.
Diagnosis is confirmed with imaging, including anteroposterior and lateral radiographs of the leg, knee, and ankle. CT may be required for complex fractures, while MRI is useful for stress or pathologic fractures. If compartment syndrome is suspected, compartment pressure measurements are indicated, with pressures >30 mm Hg or a delta pressure <20 mm Hg suggesting the need for urgent fasciotomy.
Initial management follows trauma principles, prioritizing airway, breathing, and circulation. The affected limb should be immobilized in a well-padded long leg posterior splint with slight knee flexion. Pain control and ice are important, but elevation should be avoided if compartment syndrome is suspected, as it may reduce perfusion.
Open fractures require urgent management, including irrigation, sterile dressing, tetanus prophylaxis, and early administration of antibiotics. First-generation cephalosporins such as cefazolin are used for gram-positive coverage, with additional agents like gentamicin for severe (type III) injuries and penicillin for contamination with soil or farming environments.
Most unstable fractures, open fractures, or those with neurovascular compromise require admission and orthopedic consultation. Surgical options include external fixation or intramedullary nailing, which allows earlier mobilization. Stable, minimally displaced fractures may be managed conservatively with casting and close follow-up.
Important clinical pearls include the high risk of associated injuries in high-energy trauma (such as femoral fractures or head injury) and the relatively high incidence of deep vein thrombosis following tibial fractures. Above all, vigilance for compartment syndrome is essential, as early diagnosis can be limb-saving.
Tibial and fibular shaft fractures are common long bone injuries, often resulting from trauma ranging from low-energy twisting mechanisms to high-energy direct blows such as motor vehicle collisions. The tibia is particularly vulnerable due to its subcutaneous location, and approximately 80% of tibial fractures are associated with a fibular fracture. A significant proportion (around 24%) are open fractures, making soft tissue assessment critically important.
Fractures are classified based on location (proximal, midshaft, distal), pattern (spiral, transverse, oblique, comminuted), displacement, and degree of soft tissue injury. Open fractures are further categorized using the Gustilo–Anderson classification, which ranges from type I (minimal soft tissue injury) to type III (severe soft tissue damage, including neurovascular compromise).
The mechanism of injury provides important clues. Low-energy injuries (e.g., falls, sports, twisting forces) tend to produce spiral or oblique fractures, whereas high-energy trauma (e.g., pedestrian vs. vehicle, crush injuries) often results in transverse or comminuted fractures with significant soft tissue damage. In children, special patterns such as toddler fractures (spiral distal tibia fractures) and bicycle spoke injuries should be recognized, as well as the possibility of nonaccidental trauma.
Patients typically present with severe localized pain, inability to bear weight (especially with tibial involvement), swelling, and deformity. On examination, clinicians must carefully assess for neurovascular compromise, including pulses, sensation, and motor function. Injury to the peroneal nerve, particularly with proximal fibular fractures, may lead to foot drop.
A key and potentially limb-threatening complication is compartment syndrome, which occurs in up to 8% of tibial shaft fractures. It may develop hours after injury and is characterized by pain out of proportion to the injury, pain with passive stretch, and progressive neurologic deficits. Importantly, pulses are usually still present, so their presence does not exclude the diagnosis. Early recognition is critical, as delayed treatment can result in permanent muscle and nerve damage.
Diagnosis is confirmed with imaging, including anteroposterior and lateral radiographs of the leg, knee, and ankle. CT may be required for complex fractures, while MRI is useful for stress or pathologic fractures. If compartment syndrome is suspected, compartment pressure measurements are indicated, with pressures >30 mm Hg or a delta pressure <20 mm Hg suggesting the need for urgent fasciotomy.
Initial management follows trauma principles, prioritizing airway, breathing, and circulation. The affected limb should be immobilized in a well-padded long leg posterior splint with slight knee flexion. Pain control and ice are important, but elevation should be avoided if compartment syndrome is suspected, as it may reduce perfusion.
Open fractures require urgent management, including irrigation, sterile dressing, tetanus prophylaxis, and early administration of antibiotics. First-generation cephalosporins such as cefazolin are used for gram-positive coverage, with additional agents like gentamicin for severe (type III) injuries and penicillin for contamination with soil or farming environments.
Most unstable fractures, open fractures, or those with neurovascular compromise require admission and orthopedic consultation. Surgical options include external fixation or intramedullary nailing, which allows earlier mobilization. Stable, minimally displaced fractures may be managed conservatively with casting and close follow-up.
Important clinical pearls include the high risk of associated injuries in high-energy trauma (such as femoral fractures or head injury) and the relatively high incidence of deep vein thrombosis following tibial fractures. Above all, vigilance for compartment syndrome is essential, as early diagnosis can be limb-saving.
- Published on
Emergency and Acute Medicine – Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura is a life-threatening hematologic emergency characterized by widespread microvascular thrombosis leading to multiorgan ischemia. It is classically described by a pentad consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, renal dysfunction, and fever, although most patients do not present with all five features. The most consistent findings are thrombocytopenia and hemolytic anemia, and the presence of these two findings alone is sufficient to strongly suspect the diagnosis and initiate treatment.
The underlying pathophysiology involves a deficiency of the enzyme ADAMTS13, which normally cleaves large multimers of von Willebrand factor. Without this enzyme, unusually large vWF multimers promote platelet aggregation and formation of microthrombi within small vessels. These thrombi consume platelets and mechanically shear red blood cells, resulting in hemolysis. The widespread microvascular occlusion leads to ischemia in multiple organs, particularly the brain, kidneys, and heart.
TTP can occur in several forms, including idiopathic, hereditary, drug-induced, pregnancy-associated, or secondary to infections or malignancy. It most commonly affects adults between the third and sixth decades of life and is more frequent in women. Without treatment, mortality exceeds 90%, but with modern therapy, survival rates exceed 90%, making early recognition and intervention critical.
Patients often present with nonspecific symptoms such as fatigue, weakness, and fever, along with signs of bleeding like petechiae, purpura, or mucosal hemorrhage. Neurologic manifestations are common and may include confusion, headache, seizures, or focal deficits, often fluctuating in severity. Renal involvement is usually mild compared to hemolytic uremic syndrome but may include hematuria and elevated creatinine.
Diagnosis is primarily clinical and should not be delayed while awaiting confirmatory tests. Laboratory findings typically show anemia with elevated reticulocyte count, severe thrombocytopenia, elevated lactate dehydrogenase due to hemolysis and tissue ischemia, and increased indirect bilirubin. Peripheral blood smear demonstrates schistocytes, which are fragmented red blood cells. Coagulation studies are usually normal, helping to distinguish TTP from disseminated intravascular coagulation. ADAMTS13 testing may support the diagnosis but is not required to initiate treatment.
Management is a medical emergency and begins with stabilization of airway, breathing, and circulation. The cornerstone of treatment is urgent plasma exchange therapy, which removes circulating autoantibodies and replenishes functional ADAMTS13. Plasma exchange is performed daily until platelet counts normalize and clinical improvement is observed. Fresh frozen plasma may be used as a temporary measure if exchange is not immediately available.
Supportive care includes red blood cell transfusion for significant anemia, while platelet transfusion is generally avoided unless there is life-threatening bleeding, as it may worsen thrombosis. Corticosteroids are often used to reduce immune-mediated damage, and additional therapies such as rituximab may be considered in refractory or relapsing cases. Dialysis may be required in cases of significant renal failure.
Patients require hospital admission, often to an intensive care setting, particularly if neurologic symptoms or bleeding are present. Early diagnosis and prompt initiation of plasma exchange are the most important factors in improving survival. A key clinical principle is that treatment should begin as soon as TTP is suspected, even before confirmatory testing, due to the rapid progression and high mortality of untreated disease.
Thrombotic thrombocytopenic purpura is a life-threatening hematologic emergency characterized by widespread microvascular thrombosis leading to multiorgan ischemia. It is classically described by a pentad consisting of thrombocytopenia, microangiopathic hemolytic anemia, neurologic abnormalities, renal dysfunction, and fever, although most patients do not present with all five features. The most consistent findings are thrombocytopenia and hemolytic anemia, and the presence of these two findings alone is sufficient to strongly suspect the diagnosis and initiate treatment.
The underlying pathophysiology involves a deficiency of the enzyme ADAMTS13, which normally cleaves large multimers of von Willebrand factor. Without this enzyme, unusually large vWF multimers promote platelet aggregation and formation of microthrombi within small vessels. These thrombi consume platelets and mechanically shear red blood cells, resulting in hemolysis. The widespread microvascular occlusion leads to ischemia in multiple organs, particularly the brain, kidneys, and heart.
TTP can occur in several forms, including idiopathic, hereditary, drug-induced, pregnancy-associated, or secondary to infections or malignancy. It most commonly affects adults between the third and sixth decades of life and is more frequent in women. Without treatment, mortality exceeds 90%, but with modern therapy, survival rates exceed 90%, making early recognition and intervention critical.
Patients often present with nonspecific symptoms such as fatigue, weakness, and fever, along with signs of bleeding like petechiae, purpura, or mucosal hemorrhage. Neurologic manifestations are common and may include confusion, headache, seizures, or focal deficits, often fluctuating in severity. Renal involvement is usually mild compared to hemolytic uremic syndrome but may include hematuria and elevated creatinine.
Diagnosis is primarily clinical and should not be delayed while awaiting confirmatory tests. Laboratory findings typically show anemia with elevated reticulocyte count, severe thrombocytopenia, elevated lactate dehydrogenase due to hemolysis and tissue ischemia, and increased indirect bilirubin. Peripheral blood smear demonstrates schistocytes, which are fragmented red blood cells. Coagulation studies are usually normal, helping to distinguish TTP from disseminated intravascular coagulation. ADAMTS13 testing may support the diagnosis but is not required to initiate treatment.
Management is a medical emergency and begins with stabilization of airway, breathing, and circulation. The cornerstone of treatment is urgent plasma exchange therapy, which removes circulating autoantibodies and replenishes functional ADAMTS13. Plasma exchange is performed daily until platelet counts normalize and clinical improvement is observed. Fresh frozen plasma may be used as a temporary measure if exchange is not immediately available.
Supportive care includes red blood cell transfusion for significant anemia, while platelet transfusion is generally avoided unless there is life-threatening bleeding, as it may worsen thrombosis. Corticosteroids are often used to reduce immune-mediated damage, and additional therapies such as rituximab may be considered in refractory or relapsing cases. Dialysis may be required in cases of significant renal failure.
Patients require hospital admission, often to an intensive care setting, particularly if neurologic symptoms or bleeding are present. Early diagnosis and prompt initiation of plasma exchange are the most important factors in improving survival. A key clinical principle is that treatment should begin as soon as TTP is suspected, even before confirmatory testing, due to the rapid progression and high mortality of untreated disease.
- Published on
Emergency and Acute Medicine – Syncope
Syncope is a transient loss of consciousness associated with loss of postural tone, caused by temporary cerebral hypoperfusion, particularly affecting the brainstem reticular activating system. It is most often due to a sudden drop in cardiac output, after which cerebral perfusion is restored through autonomic mechanisms and the supine position following collapse. Syncope accounts for approximately 3% of emergency department visits.
Syncope can occur in special populations with unique considerations. In pregnancy, presyncope and syncope are common due to decreased systemic vascular resistance from the placenta acting like an arteriovenous shunt, as well as compression of the inferior vena cava by the fetus. However, serious conditions such as pulmonary embolism, preeclampsia, and cardiac disease must always be excluded. In elderly patients, syncope is more frequent and often multifactorial, with higher morbidity and multiple contributing causes.
The causes of syncope are broadly categorized. Neurally mediated syncope, such as vasovagal syncope, is the most common and results from reflex vasodilation and bradycardia, often triggered by pain, fear, or emotional stress, and usually preceded by prodromal symptoms. Carotid sinus hypersensitivity may be triggered by actions such as coughing, sneezing, or micturition. Orthostatic syncope results from a sudden drop in venous return due to positional change and may be caused by dehydration, hemorrhage, autonomic dysfunction (such as diabetic neuropathy), or medications. Cardiac causes include arrhythmias, which often present suddenly without warning, and structural heart disease such as aortic stenosis, hypertrophic cardiomyopathy, myocardial infarction, pulmonary embolism, or aortic dissection. Neurologic causes are less common but include conditions such as subarachnoid hemorrhage or cerebrovascular insufficiency.
Patients often report prodromal symptoms such as lightheadedness, diaphoresis, nausea, dimming vision, and weakness. Features that suggest a life-threatening cause include sudden loss of consciousness without warning, chest pain, or palpitations. A structured history using the “6 Ps” (preprodrome, prodrome, predisposing factors, precipitating factors, passerby account, and postictal phase) can help determine the etiology. A postictal phase suggests seizure rather than syncope. Physical examination should include assessment for trauma, orthostatic vital signs, cardiovascular examination for murmurs or arrhythmias, neurologic evaluation, and screening for possible bleeding or pregnancy. In children, concerning features include syncope during exertion, events triggered by loud noise or stress, occurrence while supine, or a family history of sudden death.
Evaluation relies heavily on history and physical examination, which can determine the diagnosis in most cases. An ECG should be performed immediately to assess for ischemia, arrhythmias, conduction abnormalities, long QT syndrome, Brugada syndrome, or pre-excitation syndromes. Laboratory testing is guided by clinical suspicion and may include complete blood count for anemia or bleeding, electrolytes, cardiac enzymes, and pregnancy testing. Imaging such as chest radiography, CT angiography, or head CT is reserved for suspected cardiopulmonary or neurologic causes. Echocardiography is useful when structural heart disease is suspected.
Management begins with stabilization, including airway, breathing, and circulation, oxygen supplementation, cardiac monitoring, and intravenous access. Fluid resuscitation is indicated in suspected hypovolemia. In unstable patients, advanced cardiac life support protocols should be followed. Treatment is directed at the underlying cause, such as managing arrhythmias, treating myocardial infarction, controlling blood pressure in aortic dissection or subarachnoid hemorrhage, or administering thrombolytics for pulmonary embolism when appropriate. In cases of persistent altered mental status, a “coma cocktail” including dextrose, thiamine, and naloxone may be considered.
Disposition depends on risk stratification. High-risk patients, such as those identified by the San Francisco Syncope Rule (history of congestive heart failure, hematocrit <30%, abnormal ECG, shortness of breath, or systolic blood pressure <90 mm Hg), should be admitted for monitoring. Patients with suspected cardiac causes or significant comorbidities also require admission. Low-risk patients with vasovagal or orthostatic syncope may be discharged with close follow-up, provided they are reliable and have adequate support. Driving restrictions should be advised until evaluation is complete.
Syncope is frequently confused with seizure, but the presence of postictal confusion strongly favors seizure. Brief tonic movements or urinary incontinence may still occur in syncope. Clinicians should avoid assuming a benign vasovagal cause when syncope is associated with chest pain or headache, as these may indicate serious underlying conditions.
- Published on
Emergency and Acute Medicine - Temporomandibular Joint Injury/Syndrome
Temporomandibular joint (TMJ) injury and syndrome refer to a group of conditions involving dysfunction of the TMJ and surrounding muscles, most commonly due to myofascial pain. The TMJ is a synovial joint that allows both hinge and sliding movements, enabling functions such as chewing and speaking. TMJ disorders are common, with a large proportion of the population experiencing at least one sign during their lifetime. They most frequently affect individuals between 20 and 50 years of age, with females more commonly seeking treatment. Many cases are self-limiting and resolve spontaneously.
The condition encompasses a range of pathologies, including articular disorders, muscle dysfunction, and abnormalities in joint mobility. Hypermobility may lead to subluxation or dislocation, while hypomobility may present as trismus or restricted movement due to fibrosis or muscle spasm. Intra-articular disk disorders are also common, particularly anterior disk displacement, which may occur with or without reduction. When reduction occurs, patients often experience a clicking sound during jaw movement, whereas lack of reduction can result in limited mouth opening and mechanical obstruction.
The etiology of TMJ dysfunction is multifactorial and not fully understood. Contributing factors include bruxism (teeth grinding), trauma, malocclusion, and psychological stress. Muscle overuse and tension play a significant role in the development of myofascial pain, which is a key component of many TMJ disorders.
Patients typically present with preauricular pain that is dull, aching, and fluctuates in intensity. The pain is often exacerbated by jaw movement, which is a distinguishing feature, and may radiate to the ear, head, neck, or eye. Associated symptoms include jaw clicking or popping, limited range of motion, locking of the jaw, headache, ear fullness, tinnitus, dizziness, and neck pain. Some patients may also report nocturnal symptoms related to bruxism.
Physical examination may reveal tenderness over the TMJ and muscles of mastication, particularly the masseter muscle. Joint sounds such as clicking or popping may be detected during opening and closing of the mouth, although these findings alone are not diagnostic. Range of motion may be reduced, and deviations or malalignment of the jaw may be observed. Pain may be reproduced with dynamic loading, such as biting on an object.
Diagnosis is primarily clinical, based on history and physical examination. Imaging is generally not required unless there is suspicion of fracture, dislocation, or other structural pathology. A panoramic radiograph (Panorex) may be used as an initial screening tool, while CT is better for evaluating bony abnormalities and MRI is preferred for assessing soft tissue structures such as the articular disk.
Management is usually conservative. Initial treatment includes patient education and reassurance, as most cases are mild and self-limiting. Rest of the joint, avoidance of excessive jaw movement, application of heat or ice, and use of nonsteroidal anti-inflammatory drugs are first-line therapies. Muscle relaxants and anxiolytics may be added in selected cases. Patients are often advised to follow a soft diet and avoid triggers such as gum chewing.
In cases of acute TMJ dislocation or locking, urgent reduction may be required. This typically involves applying downward and posterior pressure on the mandible, often with the assistance of muscle relaxants or procedural sedation. Care must be taken to protect the airway during the procedure. Persistent or severe cases may benefit from physical therapy, occlusal splints, or referral to a dentist, oral and maxillofacial surgeon, or ENT specialist.
Most patients can be managed as outpatients, with admission rarely required unless reduction is unsuccessful or complications arise. Early recognition and appropriate conservative management are key, and clinicians should also consider alternative diagnoses in patients presenting with facial pain, particularly when symptoms are atypical or severe.
Temporomandibular joint (TMJ) injury and syndrome refer to a group of conditions involving dysfunction of the TMJ and surrounding muscles, most commonly due to myofascial pain. The TMJ is a synovial joint that allows both hinge and sliding movements, enabling functions such as chewing and speaking. TMJ disorders are common, with a large proportion of the population experiencing at least one sign during their lifetime. They most frequently affect individuals between 20 and 50 years of age, with females more commonly seeking treatment. Many cases are self-limiting and resolve spontaneously.
The condition encompasses a range of pathologies, including articular disorders, muscle dysfunction, and abnormalities in joint mobility. Hypermobility may lead to subluxation or dislocation, while hypomobility may present as trismus or restricted movement due to fibrosis or muscle spasm. Intra-articular disk disorders are also common, particularly anterior disk displacement, which may occur with or without reduction. When reduction occurs, patients often experience a clicking sound during jaw movement, whereas lack of reduction can result in limited mouth opening and mechanical obstruction.
The etiology of TMJ dysfunction is multifactorial and not fully understood. Contributing factors include bruxism (teeth grinding), trauma, malocclusion, and psychological stress. Muscle overuse and tension play a significant role in the development of myofascial pain, which is a key component of many TMJ disorders.
Patients typically present with preauricular pain that is dull, aching, and fluctuates in intensity. The pain is often exacerbated by jaw movement, which is a distinguishing feature, and may radiate to the ear, head, neck, or eye. Associated symptoms include jaw clicking or popping, limited range of motion, locking of the jaw, headache, ear fullness, tinnitus, dizziness, and neck pain. Some patients may also report nocturnal symptoms related to bruxism.
Physical examination may reveal tenderness over the TMJ and muscles of mastication, particularly the masseter muscle. Joint sounds such as clicking or popping may be detected during opening and closing of the mouth, although these findings alone are not diagnostic. Range of motion may be reduced, and deviations or malalignment of the jaw may be observed. Pain may be reproduced with dynamic loading, such as biting on an object.
Diagnosis is primarily clinical, based on history and physical examination. Imaging is generally not required unless there is suspicion of fracture, dislocation, or other structural pathology. A panoramic radiograph (Panorex) may be used as an initial screening tool, while CT is better for evaluating bony abnormalities and MRI is preferred for assessing soft tissue structures such as the articular disk.
Management is usually conservative. Initial treatment includes patient education and reassurance, as most cases are mild and self-limiting. Rest of the joint, avoidance of excessive jaw movement, application of heat or ice, and use of nonsteroidal anti-inflammatory drugs are first-line therapies. Muscle relaxants and anxiolytics may be added in selected cases. Patients are often advised to follow a soft diet and avoid triggers such as gum chewing.
In cases of acute TMJ dislocation or locking, urgent reduction may be required. This typically involves applying downward and posterior pressure on the mandible, often with the assistance of muscle relaxants or procedural sedation. Care must be taken to protect the airway during the procedure. Persistent or severe cases may benefit from physical therapy, occlusal splints, or referral to a dentist, oral and maxillofacial surgeon, or ENT specialist.
Most patients can be managed as outpatients, with admission rarely required unless reduction is unsuccessful or complications arise. Early recognition and appropriate conservative management are key, and clinicians should also consider alternative diagnoses in patients presenting with facial pain, particularly when symptoms are atypical or severe.
- Published on
Emergency and Acute Medicine - Taser Injuries
Taser injuries result from exposure to conducted energy weapons (CEWs), which are designed as less-lethal tools commonly used in law enforcement. These devices deliver a high-voltage, low-amperage electrical current that disrupts voluntary control of skeletal muscles, leading to temporary incapacitation and pain. Some devices require direct contact with the skin, while others fire barbed probes connected by wires that can deliver electrical current from a distance. The physiologic effects depend on factors such as probe placement, distance between probes, duration of exposure, and the individual’s underlying condition.
Cutaneous effects are the most common and typically include small puncture wounds from the barbed probes and localized skin marks referred to as “signature marks.” Although usually minor, deeper penetration can occur, particularly in sensitive areas such as the eyes, face, neck, or genitals, where underlying structures may be at risk. Skeletal injuries may occur as secondary trauma, most often due to falls following incapacitation, and can include fractures such as vertebral compression injuries. Muscle effects include strains and, in rare cases, rhabdomyolysis, especially with prolonged or repeated exposure or when associated with underlying conditions such as excited delirium syndrome (ExDS).
Cardiovascular effects are generally minimal in healthy individuals, with little evidence of significant ECG changes or myocardial injury. However, there is a theoretical risk of arrhythmias, including ventricular fibrillation, particularly if the electrical discharge occurs over the heart during a vulnerable phase of the cardiac cycle. Rare cases of atrial fibrillation have been reported. In patients with implanted cardiac devices such as pacemakers or defibrillators, the electrical activity from a CEW may be misinterpreted, potentially triggering device responses.
Neurologic complications are uncommon but can include seizures or, rarely, direct penetration injuries such as skull involvement. Respiratory compromise was initially a concern, but studies suggest that ventilation is generally maintained or even increased during CEW exposure. The overall clinical picture may also be influenced by the circumstances leading to CEW use, particularly in individuals with agitation or excited delirium, which itself carries significant morbidity and mortality.
Evaluation begins with a focused history, including the type of device used, number and duration of electrical discharges, and the location of probe contact. Physical examination should carefully assess probe entry sites and screen for secondary injuries from falls or muscle contractions. Particular attention should be paid to high-risk areas such as the eyes, neck, and groin. In patients who are alert, stable, and asymptomatic, extensive testing is generally not required. Investigations should instead be guided by clinical findings or underlying conditions, such as suspected trauma, altered mental status, or signs of excited delirium.
Management is primarily supportive and directed at associated injuries rather than the electrical exposure itself. In stable patients with no complications, treatment consists of probe removal, local wound care, and tetanus prophylaxis if indicated. Probe removal involves stabilizing the surrounding skin and applying steady traction to extract the barb. Patients with agitation or suspected excited delirium require prompt sedation and supportive care. Cardiac monitoring and further evaluation are indicated if arrhythmias or underlying cardiac disease are suspected.
Disposition depends on clinical status. Patients who are alert, hemodynamically stable, and without significant injury can be discharged after appropriate wound care and observation. Admission is required for those with cardiac instability, serious traumatic injuries, or excited delirium syndrome. Special consideration should be given to vulnerable populations such as pregnant patients, who may require fetal monitoring, and individuals with implanted cardiac devices.
A key consideration in these cases is the recognition of secondary injuries and underlying conditions rather than focusing solely on the CEW exposure. Patients presenting after Taser use should be carefully assessed for trauma, intoxication, or excited delirium, as these factors often contribute more significantly to morbidity than the electrical exposure itself.
Taser injuries result from exposure to conducted energy weapons (CEWs), which are designed as less-lethal tools commonly used in law enforcement. These devices deliver a high-voltage, low-amperage electrical current that disrupts voluntary control of skeletal muscles, leading to temporary incapacitation and pain. Some devices require direct contact with the skin, while others fire barbed probes connected by wires that can deliver electrical current from a distance. The physiologic effects depend on factors such as probe placement, distance between probes, duration of exposure, and the individual’s underlying condition.
Cutaneous effects are the most common and typically include small puncture wounds from the barbed probes and localized skin marks referred to as “signature marks.” Although usually minor, deeper penetration can occur, particularly in sensitive areas such as the eyes, face, neck, or genitals, where underlying structures may be at risk. Skeletal injuries may occur as secondary trauma, most often due to falls following incapacitation, and can include fractures such as vertebral compression injuries. Muscle effects include strains and, in rare cases, rhabdomyolysis, especially with prolonged or repeated exposure or when associated with underlying conditions such as excited delirium syndrome (ExDS).
Cardiovascular effects are generally minimal in healthy individuals, with little evidence of significant ECG changes or myocardial injury. However, there is a theoretical risk of arrhythmias, including ventricular fibrillation, particularly if the electrical discharge occurs over the heart during a vulnerable phase of the cardiac cycle. Rare cases of atrial fibrillation have been reported. In patients with implanted cardiac devices such as pacemakers or defibrillators, the electrical activity from a CEW may be misinterpreted, potentially triggering device responses.
Neurologic complications are uncommon but can include seizures or, rarely, direct penetration injuries such as skull involvement. Respiratory compromise was initially a concern, but studies suggest that ventilation is generally maintained or even increased during CEW exposure. The overall clinical picture may also be influenced by the circumstances leading to CEW use, particularly in individuals with agitation or excited delirium, which itself carries significant morbidity and mortality.
Evaluation begins with a focused history, including the type of device used, number and duration of electrical discharges, and the location of probe contact. Physical examination should carefully assess probe entry sites and screen for secondary injuries from falls or muscle contractions. Particular attention should be paid to high-risk areas such as the eyes, neck, and groin. In patients who are alert, stable, and asymptomatic, extensive testing is generally not required. Investigations should instead be guided by clinical findings or underlying conditions, such as suspected trauma, altered mental status, or signs of excited delirium.
Management is primarily supportive and directed at associated injuries rather than the electrical exposure itself. In stable patients with no complications, treatment consists of probe removal, local wound care, and tetanus prophylaxis if indicated. Probe removal involves stabilizing the surrounding skin and applying steady traction to extract the barb. Patients with agitation or suspected excited delirium require prompt sedation and supportive care. Cardiac monitoring and further evaluation are indicated if arrhythmias or underlying cardiac disease are suspected.
Disposition depends on clinical status. Patients who are alert, hemodynamically stable, and without significant injury can be discharged after appropriate wound care and observation. Admission is required for those with cardiac instability, serious traumatic injuries, or excited delirium syndrome. Special consideration should be given to vulnerable populations such as pregnant patients, who may require fetal monitoring, and individuals with implanted cardiac devices.
A key consideration in these cases is the recognition of secondary injuries and underlying conditions rather than focusing solely on the CEW exposure. Patients presenting after Taser use should be carefully assessed for trauma, intoxication, or excited delirium, as these factors often contribute more significantly to morbidity than the electrical exposure itself.
- Published on
Emergency and Acute Medicine - Tachydysrhythmias
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
Tachydysrhythmias refer to any disturbance of cardiac rhythm resulting in a heart rate greater than 100 beats per minute. They encompass a broad spectrum of arrhythmias originating from different parts of the cardiac conduction system, ranging from relatively benign sinus tachycardia to life-threatening ventricular fibrillation. The classification is typically based on the origin of the rhythm and the width of the QRS complex, distinguishing between supraventricular and ventricular causes.
Sinus tachycardia is a narrow-complex, regular rhythm usually between 100 and 150 beats per minute and represents a physiologic response to stressors such as hypovolemia, hypoxia, pain, anxiety, infection, or anemia. It results from increased sympathetic activity or reduced vagal tone and should prompt evaluation for an underlying cause rather than primary rhythm management.
Supraventricular tachycardias (SVTs) originate above the His bundle and may be regular or irregular. Regular SVTs include atrial tachycardia and junctional tachycardia, while irregular SVTs include atrial fibrillation, atrial flutter, and multifocal atrial tachycardia. Atrial fibrillation is the most common pathologic SVT encountered in emergency settings and is characterized by an irregularly irregular rhythm without distinct P waves. Atrial flutter typically demonstrates a sawtooth pattern on ECG. These rhythms are often associated with conditions such as hypertension, coronary artery disease, valvular disease, pulmonary disorders, or metabolic abnormalities.
Ventricular tachycardia (VT) is defined as three or more consecutive ventricular beats at a rate exceeding 100 beats per minute and is commonly associated with structural heart disease, particularly prior myocardial infarction. It may present as monomorphic or polymorphic VT and can rapidly deteriorate into ventricular fibrillation (VF), a chaotic rhythm with no effective cardiac output and a leading cause of sudden cardiac death. Torsades de pointes is a specific form of polymorphic VT associated with prolonged QT interval and is often triggered by medications or electrolyte imbalances such as hypokalemia or hypomagnesemia.
Clinical presentation varies widely, ranging from asymptomatic episodes to severe symptoms such as palpitations, dizziness, dyspnea, chest pain, syncope, or cardiac arrest. Signs of hemodynamic instability include hypotension, altered mental status, chest pain, and pulmonary edema, and these findings necessitate immediate intervention. A careful history and physical examination should focus on identifying underlying cardiac disease, triggers, and the stability of the patient.
Evaluation begins with assessment of airway, breathing, and circulation, followed by rapid determination of whether the patient is stable or unstable. A 12-lead ECG is essential to classify the rhythm and guide management. Laboratory testing is directed toward identifying underlying causes such as electrolyte disturbances, ischemia, or metabolic abnormalities.
Management depends primarily on the patient’s hemodynamic status and the type of rhythm. Unstable patients require immediate synchronized cardioversion for most tachydysrhythmias or defibrillation in cases of pulseless VT or VF, following advanced cardiac life support protocols. Stable patients with narrow-complex tachycardias may respond to vagal maneuvers or pharmacologic therapy such as adenosine. Atrial fibrillation and flutter are typically managed with rate control using beta-blockers or calcium channel blockers, with consideration of anticoagulation depending on duration and risk factors.
Wide-complex tachycardias should be presumed to be ventricular in origin until proven otherwise, especially in older patients or those with structural heart disease. Antiarrhythmic agents such as amiodarone or procainamide are commonly used, while caution is required with AV nodal blocking agents in the presence of accessory pathways. Torsades de pointes is treated with intravenous magnesium and correction of underlying electrolyte abnormalities.
Patients with serious arrhythmias such as VT, VF, persistent SVT, or suspected cardiac ischemia require hospital admission and monitoring. Those with transient, well-tolerated supraventricular rhythms that resolve without complications may be discharged with appropriate follow-up. Prompt recognition and appropriate management are critical, as tachydysrhythmias can rapidly progress to life-threatening conditions if untreated.
- Published on
Emergency and Acute Medicine - Syphilis
Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum. It is acquired through contact with infected mucous membranes or disrupted skin and remains a significant global health issue, with millions of new cases diagnosed annually. The disease progresses through distinct stages—primary, secondary, latent, and tertiary—each with characteristic clinical features.
Primary syphilis typically presents after an incubation period of about three weeks. The hallmark lesion is a painless chancre at the site of inoculation, which appears as a clean-based, well-demarcated ulcer, usually on the genitalia, rectum, or oral mucosa. Regional lymphadenopathy is common, and the lesion heals spontaneously within three to six weeks, often leading to missed diagnosis if not recognized early.
Secondary syphilis develops several weeks after the primary stage due to hematogenous dissemination of the organism. It is characterized by a diffuse, symmetric rash that often involves the palms and soles, a key diagnostic clue. Lesions may be maculopapular, papular, or polymorphic. Other features include mucous patches, condyloma lata (broad, moist, highly infectious lesions in intertriginous areas), generalized lymphadenopathy, and systemic symptoms such as fever, malaise, sore throat, and weight loss. Less common findings include patchy “moth-eaten” alopecia and ocular or neurologic involvement. This stage also resolves spontaneously if untreated.
Following resolution of secondary symptoms, the disease enters a latent phase, during which patients are asymptomatic but serologically positive. Early latent syphilis remains potentially infectious, while late latent syphilis is generally not, except in pregnancy where vertical transmission can occur. Without treatment, a subset of patients progress to tertiary syphilis years to decades later.
Tertiary syphilis is a destructive phase that may involve multiple organ systems. Neurosyphilis is the most common manifestation and can present with meningitis, cranial nerve deficits, dementia, or tabes dorsalis, which involves degeneration of the spinal cord leading to sensory loss and gait abnormalities. Cardiovascular syphilis may cause aortic aneurysm or aortic valve insufficiency. Gummatous syphilis results in granulomatous lesions affecting skin, bone, or internal organs. Syphilis is often called the “great imitator” because its manifestations can resemble many other diseases.
Congenital syphilis occurs when infection is transmitted in utero. Infants may present with hepatosplenomegaly, rash, jaundice, and nasal discharge (“snuffles”), while older children may develop characteristic deformities such as Hutchinson teeth, saddle nose, and hearing loss.
Diagnosis relies primarily on serologic testing. Nontreponemal tests such as rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) are used for screening and monitoring treatment response, while treponemal tests such as fluorescent treponemal antibody absorption (FTA-ABS) confirm the diagnosis and remain positive for life. Dark-field microscopy can identify organisms in early lesions, and cerebrospinal fluid analysis is required when neurosyphilis is suspected.
Treatment is centered on penicillin, which remains the gold standard. Early stages are treated with a single intramuscular dose of benzathine penicillin G, while late latent disease requires multiple doses over several weeks. Neurosyphilis requires intravenous penicillin therapy. Patients allergic to penicillin, particularly pregnant women, should undergo desensitization. A Jarisch–Herxheimer reaction, characterized by fever and worsening symptoms shortly after treatment, may occur but is self-limited.
Follow-up is essential to ensure treatment success, with serial monitoring of antibody titers over time. Sexual partners should be tested and treated as necessary, and patients should also be screened for other sexually transmitted infections, including HIV. Early recognition and treatment are critical to prevent progression to late-stage disease and its serious complications.
Syphilis is a sexually transmitted infection caused by the spirochete bacterium Treponema pallidum. It is acquired through contact with infected mucous membranes or disrupted skin and remains a significant global health issue, with millions of new cases diagnosed annually. The disease progresses through distinct stages—primary, secondary, latent, and tertiary—each with characteristic clinical features.
Primary syphilis typically presents after an incubation period of about three weeks. The hallmark lesion is a painless chancre at the site of inoculation, which appears as a clean-based, well-demarcated ulcer, usually on the genitalia, rectum, or oral mucosa. Regional lymphadenopathy is common, and the lesion heals spontaneously within three to six weeks, often leading to missed diagnosis if not recognized early.
Secondary syphilis develops several weeks after the primary stage due to hematogenous dissemination of the organism. It is characterized by a diffuse, symmetric rash that often involves the palms and soles, a key diagnostic clue. Lesions may be maculopapular, papular, or polymorphic. Other features include mucous patches, condyloma lata (broad, moist, highly infectious lesions in intertriginous areas), generalized lymphadenopathy, and systemic symptoms such as fever, malaise, sore throat, and weight loss. Less common findings include patchy “moth-eaten” alopecia and ocular or neurologic involvement. This stage also resolves spontaneously if untreated.
Following resolution of secondary symptoms, the disease enters a latent phase, during which patients are asymptomatic but serologically positive. Early latent syphilis remains potentially infectious, while late latent syphilis is generally not, except in pregnancy where vertical transmission can occur. Without treatment, a subset of patients progress to tertiary syphilis years to decades later.
Tertiary syphilis is a destructive phase that may involve multiple organ systems. Neurosyphilis is the most common manifestation and can present with meningitis, cranial nerve deficits, dementia, or tabes dorsalis, which involves degeneration of the spinal cord leading to sensory loss and gait abnormalities. Cardiovascular syphilis may cause aortic aneurysm or aortic valve insufficiency. Gummatous syphilis results in granulomatous lesions affecting skin, bone, or internal organs. Syphilis is often called the “great imitator” because its manifestations can resemble many other diseases.
Congenital syphilis occurs when infection is transmitted in utero. Infants may present with hepatosplenomegaly, rash, jaundice, and nasal discharge (“snuffles”), while older children may develop characteristic deformities such as Hutchinson teeth, saddle nose, and hearing loss.
Diagnosis relies primarily on serologic testing. Nontreponemal tests such as rapid plasma reagin (RPR) or Venereal Disease Research Laboratory (VDRL) are used for screening and monitoring treatment response, while treponemal tests such as fluorescent treponemal antibody absorption (FTA-ABS) confirm the diagnosis and remain positive for life. Dark-field microscopy can identify organisms in early lesions, and cerebrospinal fluid analysis is required when neurosyphilis is suspected.
Treatment is centered on penicillin, which remains the gold standard. Early stages are treated with a single intramuscular dose of benzathine penicillin G, while late latent disease requires multiple doses over several weeks. Neurosyphilis requires intravenous penicillin therapy. Patients allergic to penicillin, particularly pregnant women, should undergo desensitization. A Jarisch–Herxheimer reaction, characterized by fever and worsening symptoms shortly after treatment, may occur but is self-limited.
Follow-up is essential to ensure treatment success, with serial monitoring of antibody titers over time. Sexual partners should be tested and treated as necessary, and patients should also be screened for other sexually transmitted infections, including HIV. Early recognition and treatment are critical to prevent progression to late-stage disease and its serious complications.
- Published on
Emergency and Acute Medicine - Toxic Synovitis
Toxic synovitis is a nonspecific, self-limiting inflammation of the synovium associated with an effusion, most commonly affecting the hip joint in children. It is the most frequent cause of acute hip pain and limping in children between 3 and 10 years of age, particularly in those aged 3 to 6 years. Boys are affected more commonly than girls, and the right hip is more frequently involved than the left. Although it can involve other joints, the hip is by far the most typical site.
The exact cause of toxic synovitis is unknown, but it is often preceded by a viral illness, particularly an upper respiratory infection, in about half of cases. This association suggests a possible postinfectious or inflammatory response rather than a direct infection of the joint.
Children typically present with an acute onset of unilateral hip pain, which may radiate to the anteromedial thigh or even the knee. Pain is usually worse with weight bearing, leading to a limp or refusal to walk. There is often a low-grade fever, generally below 38.5°C, and the child appears nontoxic. On examination, there is decreased range of motion of the affected hip due to pain, and the hip is commonly held in a position of flexion and external rotation to maximize comfort. High fever or a toxic appearance should raise concern for more serious conditions such as septic arthritis.
Evaluation is primarily aimed at excluding more serious diagnoses. Plain radiographs of the hip are usually normal but may help identify alternative causes of pain or show joint effusion. Laboratory tests such as white blood cell count, C-reactive protein, and erythrocyte sedimentation rate may be normal or mildly elevated, but they are not specific. If these inflammatory markers are normal and the child is able to bear weight, toxic synovitis is more likely. Ultrasound can be useful to detect joint effusion and guide aspiration if needed. Advanced imaging such as MRI or bone scan is reserved for unclear or recurrent cases or when conditions such as Legg–Calvé–Perthes disease or osteomyelitis are suspected. Joint aspiration is generally unnecessary unless septic arthritis is strongly suspected.
Management is conservative, as the condition is self-limiting. Treatment includes rest, positioning the hip for comfort (usually flexion and external rotation), and administration of nonsteroidal anti-inflammatory drugs. Heat may be applied for additional comfort. Antibiotics and steroids are not indicated. Some clinicians recommend limiting weight bearing for several days after symptom improvement to reduce the risk of recurrence.
Disposition depends on severity. Most patients can be discharged once more serious conditions are excluded, provided there is reliable follow-up. Hospitalization may be required in cases of severe pain or significant joint effusion requiring close observation and analgesia. Follow-up with a pediatric orthopedic specialist within one to two weeks is recommended, and repeat imaging at around six months is advised to exclude the development of Legg–Calvé–Perthes disease.
Toxic synovitis is largely a clinical diagnosis based on history and physical examination, with key features being low-grade fever and the ability to bear weight. Nearly all children recover completely within two weeks without long-term complications. However, a small proportion may experience recurrence, and approximately 2 to 10 percent may later develop Legg–Calvé–Perthes disease, making close follow-up essential.
Toxic synovitis is a nonspecific, self-limiting inflammation of the synovium associated with an effusion, most commonly affecting the hip joint in children. It is the most frequent cause of acute hip pain and limping in children between 3 and 10 years of age, particularly in those aged 3 to 6 years. Boys are affected more commonly than girls, and the right hip is more frequently involved than the left. Although it can involve other joints, the hip is by far the most typical site.
The exact cause of toxic synovitis is unknown, but it is often preceded by a viral illness, particularly an upper respiratory infection, in about half of cases. This association suggests a possible postinfectious or inflammatory response rather than a direct infection of the joint.
Children typically present with an acute onset of unilateral hip pain, which may radiate to the anteromedial thigh or even the knee. Pain is usually worse with weight bearing, leading to a limp or refusal to walk. There is often a low-grade fever, generally below 38.5°C, and the child appears nontoxic. On examination, there is decreased range of motion of the affected hip due to pain, and the hip is commonly held in a position of flexion and external rotation to maximize comfort. High fever or a toxic appearance should raise concern for more serious conditions such as septic arthritis.
Evaluation is primarily aimed at excluding more serious diagnoses. Plain radiographs of the hip are usually normal but may help identify alternative causes of pain or show joint effusion. Laboratory tests such as white blood cell count, C-reactive protein, and erythrocyte sedimentation rate may be normal or mildly elevated, but they are not specific. If these inflammatory markers are normal and the child is able to bear weight, toxic synovitis is more likely. Ultrasound can be useful to detect joint effusion and guide aspiration if needed. Advanced imaging such as MRI or bone scan is reserved for unclear or recurrent cases or when conditions such as Legg–Calvé–Perthes disease or osteomyelitis are suspected. Joint aspiration is generally unnecessary unless septic arthritis is strongly suspected.
Management is conservative, as the condition is self-limiting. Treatment includes rest, positioning the hip for comfort (usually flexion and external rotation), and administration of nonsteroidal anti-inflammatory drugs. Heat may be applied for additional comfort. Antibiotics and steroids are not indicated. Some clinicians recommend limiting weight bearing for several days after symptom improvement to reduce the risk of recurrence.
Disposition depends on severity. Most patients can be discharged once more serious conditions are excluded, provided there is reliable follow-up. Hospitalization may be required in cases of severe pain or significant joint effusion requiring close observation and analgesia. Follow-up with a pediatric orthopedic specialist within one to two weeks is recommended, and repeat imaging at around six months is advised to exclude the development of Legg–Calvé–Perthes disease.
Toxic synovitis is largely a clinical diagnosis based on history and physical examination, with key features being low-grade fever and the ability to bear weight. Nearly all children recover completely within two weeks without long-term complications. However, a small proportion may experience recurrence, and approximately 2 to 10 percent may later develop Legg–Calvé–Perthes disease, making close follow-up essential.
